137 related articles for article (PubMed ID: 30630980)
1. FLT3 ligand plasma levels in acute myeloid leukemia.
Peterlin P; Gaschet J; Guillaume T; Garnier A; Eveillard M; Le Bourgeois A; Cherel M; Debord C; Le Bris Y; Theisen O; Mahé B; Dubruille V; Godon C; Robillard N; Wuilleme S; Touzeau C; Gastinne T; Blin N; Lok A; Bonnet A; Le Gouill S; Moreau P; Béné MC; Chevallier P
Haematologica; 2019 Jun; 104(6):e240-e243. PubMed ID: 30630980
[No Abstract] [Full Text] [Related]
2. Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia.
Milne P; Wilhelm-Benartzi C; Grunwald MR; Bigley V; Dillon R; Freeman SD; Gallagher K; Publicover A; Pagan S; Marr H; Jones GL; Dickinson AM; Grech A; Burnett AK; Russell NH; Levis M; Knapper S; Collin M
Blood Adv; 2019 Oct; 3(20):3052-3061. PubMed ID: 31648336
[TBL] [Abstract][Full Text] [Related]
3. High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia.
Zhu GZ; Yang YL; Zhang YJ; Liu W; Li MP; Zeng WJ; Zhao XL; Chen XP
Cell Physiol Biochem; 2017; 42(5):1973-1984. PubMed ID: 28793301
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state.
Cheng WY; Zhu YM; Liu Z; Weng XQ; Sui JN; Chen YS; Wang SY; Shen Y
Blood Cancer J; 2018 Jun; 8(6):53. PubMed ID: 29891838
[No Abstract] [Full Text] [Related]
5. A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.
Peterlin P; Gaschet J; Guillaume T; Garnier A; Eveillard M; Le Bourgeois A; Cherel M; Debord C; Le Bris Y; Theisen O; Godon C; Mahé B; Dubruille V; Wuilleme S; Touzeau C; Gastinne T; Blin N; Lok A; Tessoulin B; Le Gouill S; Moreau P; Béné MC; Chevallier P
Cancer Med; 2021 Jan; 10(2):642-648. PubMed ID: 33369136
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.
Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H
Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system.
Gao N; Yu WZ; Guo NJ; Wang XX; Sun JR
Leuk Lymphoma; 2017 Jun; 58(6):1394-1402. PubMed ID: 27736291
[TBL] [Abstract][Full Text] [Related]
8. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
Kayser S; Benner A; Thiede C; Martens U; Huber J; Stadtherr P; Janssen JW; Röllig C; Uppenkamp MJ; Bochtler T; Hegenbart U; Ehninger G; Ho AD; Dreger P; Krämer A
Blood Cancer J; 2016 Jul; 6(7):e449. PubMed ID: 27471865
[TBL] [Abstract][Full Text] [Related]
10. Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia.
Bertoli S; Paubelle E; Bérard E; Saland E; Thomas X; Tavitian S; Larcher MV; Vergez F; Delabesse E; Sarry A; Huguet F; Larrue C; Bosc C; Farge T; Sarry JE; Michallet M; Récher C
Eur J Haematol; 2019 Feb; 102(2):131-142. PubMed ID: 30325535
[TBL] [Abstract][Full Text] [Related]
11. Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study.
Nasilowska-Adamska B; Czyz A; Markiewicz M; Rzepecki P; Piatkowska-Jakubas B; Paluszewska M; Dzierzak-Mietla M; Solarska I; Borg K; Prochorec-Sobieszek M; Szydlo R; Lewandowski K; Skotnicki A; Jedrzejczak WW; Kyrcz-Krzemien S; Komarnicki M; Warzocha K
Eur J Haematol; 2016 Mar; 96(3):236-44. PubMed ID: 25912052
[TBL] [Abstract][Full Text] [Related]
12. FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia.
Perry M; Bertoli S; Rocher C; Hayette S; Ducastelle S; Barraco F; Labussière-Wallet H; Salles G; Recher C; Thomas X; Paubelle E
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e545-e550. PubMed ID: 30082225
[TBL] [Abstract][Full Text] [Related]
13. T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Canaani J; Labopin M; Huang XJ; Arcese W; Ciceri F; Blaise D; Irrera G; Corral LL; Bruno B; Santarone S; Van Lint MT; Vitek A; Esteve J; Mohty M; Nagler A
Am J Hematol; 2018 Jun; 93(6):736-744. PubMed ID: 29498106
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
Damiani D; Tiribelli M; Raspadori D; Sirianni S; Meneghel A; Cavalllin M; Michelutti A; Toffoletti E; Geromin A; Simeone E; Bocchia M; Fanin R
Oncotarget; 2015 Oct; 6(30):30212-21. PubMed ID: 26338961
[TBL] [Abstract][Full Text] [Related]
15. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
Chen X; Xie H; Wood BL; Walter RB; Pagel JM; Becker PS; Sandhu VK; Abkowitz JL; Appelbaum FR; Estey EH
J Clin Oncol; 2015 Apr; 33(11):1258-64. PubMed ID: 25732155
[TBL] [Abstract][Full Text] [Related]
16. Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.
Hemmati PG; Vuong LG; Terwey TH; Jehn CF; le Coutre P; Penack O; Na IK; Dörken B; Arnold R
Eur J Haematol; 2017 Feb; 98(2):160-168. PubMed ID: 27706846
[TBL] [Abstract][Full Text] [Related]
17. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
18. Independent Associations Between Glomerular Filtration Rate and Serum Bilirubin Level and Early Mortality in Acute Myeloid Leukemia.
Bezerra ED; Othus M; Shawn C; Percival ME; Gardner K; Walter RB; Becker PS; Hendrie PC; Estey EH
Clin Lymphoma Myeloma Leuk; 2019 Dec; 19(12):e633-e635. PubMed ID: 31648955
[No Abstract] [Full Text] [Related]
19. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
20. High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.
Tiribelli M; Raspadori D; Geromin A; Cavallin M; Sirianni S; Simeone E; Bocchia M; Fanin R; Damiani D
Leuk Res; 2017 Jul; 58():31-38. PubMed ID: 28407515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
